Conference
Can Low-Molecular-Weight Heparin Be Safely Used as Prophylaxis Against Venous Thromboembolism in Critically Ill Patients with End-Stage Renal Disease? A Subgroup Analysis of the Protect Trial
Authors
Douketis J; Pai M; Walsh M; Heels-Ansdell D; Zytaruk N; Cook D
Volume
87
Pagination
pp. S199-S200
Publisher
WILEY-BLACKWELL
Publication Date
May 1, 2012
Conference proceedings
AMERICAN JOURNAL OF HEMATOLOGY
ISSN
0361-8609
